carvedilol has been researched along with Fasting Hypoglycemia in 8 studies
Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Glycemic Effect in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial compared the metabolic effects of two beta-blockers in people with type 2 diabetes and hypertension treated with renin-angiotensin system (RAS) blockade and found differences in metabolic outcomes." | 5.12 | beta-blocker use and diabetes symptom score: results from the GEMINI study. ( Anderson, KM; Bakris, GL; Bell, DS; Dalal, MR; Fonseca, V; Iyengar, M; Katholi, RE; Lukas, MA; McGill, JB; Messerli, FH; Phillips, RA; Raskin, P; Wright, JT, 2007) |
| "Carvedilol administration during pregnancy was associated with neonatal hypoglycemia; however, it did not occur in a time- or dose-dependent manner." | 4.31 | α/β- and β-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age. ( Inai, K; Kubota, K; Shimada, E; Shinohara, T, 2023) |
| "Treatment with carvedilol restored VMH lactate levels and improved the adrenaline (epinephrine) responses." | 1.51 | Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats. ( Chan, O; Farhat, R; Fisher, SJ; Knight, N; Sejling, AS; Su, G, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kubota, K | 1 |
| Inai, K | 1 |
| Shimada, E | 1 |
| Shinohara, T | 1 |
| Carnovale, C | 1 |
| Gringeri, M | 1 |
| Battini, V | 1 |
| Mosini, G | 1 |
| Invernizzi, E | 1 |
| Mazhar, F | 1 |
| Bergamaschi, F | 1 |
| Fumagalli, M | 1 |
| Zuccotti, G | 1 |
| Clementi, E | 1 |
| Radice, S | 1 |
| Fabiano, V | 1 |
| Farhat, R | 2 |
| de Santana-Van Vliet, E | 1 |
| Su, G | 2 |
| Neely, L | 1 |
| Benally, T | 1 |
| Chan, O | 2 |
| Maekawa, M | 1 |
| Takahashi, A | 1 |
| Miki, Y | 1 |
| Zullo, AR | 1 |
| Hersey, M | 1 |
| Lee, Y | 1 |
| Sharmin, S | 1 |
| Bosco, E | 1 |
| Daiello, LA | 1 |
| Shah, NR | 1 |
| Mor, V | 1 |
| Boscardin, WJ | 1 |
| Berard-Collins, CM | 1 |
| Dore, DD | 1 |
| Steinman, MA | 1 |
| Sejling, AS | 1 |
| Knight, N | 1 |
| Fisher, SJ | 1 |
| Martín-Gómez, A | 1 |
| Palacios-Gómez, ME | 1 |
| García-Marcos, SA | 1 |
| McGill, JB | 1 |
| Bakris, GL | 1 |
| Fonseca, V | 1 |
| Raskin, P | 1 |
| Messerli, FH | 1 |
| Phillips, RA | 1 |
| Katholi, RE | 1 |
| Wright, JT | 1 |
| Iyengar, M | 1 |
| Anderson, KM | 1 |
| Lukas, MA | 1 |
| Dalal, MR | 1 |
| Bell, DS | 1 |
1 review available for carvedilol and Fasting Hypoglycemia
| Article | Year |
|---|---|
Beta-blocker-associated hypoglycaemia: New insights from a real-world pharmacovigilance study.
Topics: Adrenergic beta-Antagonists; Carvedilol; Child; Humans; Hypoglycemia; Odds Ratio; Pharmacovigilance | 2021 |
1 trial available for carvedilol and Fasting Hypoglycemia
| Article | Year |
|---|---|
beta-blocker use and diabetes symptom score: results from the GEMINI study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Carvedilol; Cognition; Diab | 2007 |
6 other studies available for carvedilol and Fasting Hypoglycemia
| Article | Year |
|---|---|
α/β- and β-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age.
Topics: Adrenergic beta-Antagonists; Carvedilol; Female; Gestational Age; Humans; Hypoglycemia; Infant, Newb | 2023 |
Carvedilol prevents impairment of the counterregulatory response in recurrently hypoglycaemic diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Awareness; Carvedilol; Deoxyglucose; Diabetes Mellitus, Experi | 2021 |
Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diabetic Nephropathies; Female; Humans; Hypogly | 2017 |
Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" β-blockers in older nursing home residents with diabetes after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Blood Glucose; Carvedilol; Diabetes Mellitus, Type 2 | 2018 |
Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Blood Glucose; Body Weight; Carvedilol; Catheteriza | 2019 |
Severe intradialytic hypoglycemia associated with marijuana use.
Topics: Cannabis; Carbazoles; Carvedilol; Diagnosis, Differential; Glucose; Hemodialysis Solutions; Humans; | 2015 |